Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mitral Regurgitation IV: Nursing Management01:28

Mitral Regurgitation IV: Nursing Management

526
Mitral regurgitation (MR) is a condition where the mitral valve does not close properly, leading to the backward flow of blood from the left ventricle into the left atrium during systole. This condition can arise from various causes, including rheumatic fever, infective endocarditis, or degenerative valve disease. Effective nursing management is crucial to optimizing patient outcomes and involves comprehensive assessment and targeted interventions.Comprehensive Patient AssessmentA detailed...
526
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

585
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
585
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

468
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
468
Mitral Valve Prolapse III: Nursing Management01:19

Mitral Valve Prolapse III: Nursing Management

534
The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
534
Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

1.1K
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
1.1K
Mitral Stenosis IV: Nursing Management01:27

Mitral Stenosis IV: Nursing Management

381
A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...
381

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Intraprocedural Findings and Outcomes of Redo Procedures After Voltage-Guided Ablation of Persistent Atrial Fibrillation.

Journal of clinical medicine·2026
Same author

Characteristics and outcomes of patients with heart failure and reduced left ventricular ejection fraction in relation to sodium-glucose cotransporter-2 inhibitor treatment: real-world data from the multicentre H<sup>2</sup>-registry.

Clinical research in cardiology : official journal of the German Cardiac Society·2026
Same author

Balloon Postdilation After Transcatheter Aortic Valve Implantation (TAVI) Among Self- and Balloon-Expandable Valves: A Systematic Review and Meta-Analysis.

The American journal of cardiology·2025
Same author

Transcatheter aortic valve implantation with the Trilogy valve for symptomatic native aortic regurgitation (ALIGN-AR): a pivotal, multicentre, single-arm, investigational device exemption study.

Lancet (London, England)·2025
Same author

Rationale and design of the TRIC-I-HF-DZHK24 (TRICuspid Intervention in Heart Failure) trial.

European journal of heart failure·2025
Same author

Right Ventricular-Pulmonary Artery Coupling in Tricuspid Regurgitation: Prognostic Value and Impact of Treatment Strategy.

JACC. Cardiovascular interventions·2025

Related Experiment Video

Updated: Apr 3, 2026

Cox-Maze IV Procedure Concomitant with Valvular Surgery In Situs Inversus Dextrocardia: A Single-Center Experience in China
08:42

Cox-Maze IV Procedure Concomitant with Valvular Surgery In Situs Inversus Dextrocardia: A Single-Center Experience in China

Published on: February 11, 2022

4.5K

Tricuspid valve interventions in 2015.

Alexander Lauten1, Hans R Figulla

  • 1Charité-Universitaetsmedizin Berlin, Campus Benjamin Franklin, Department of Cardiology, Berlin, Germany.

Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology
|September 19, 2015
PubMed
Summary

Tricuspid regurgitation is undertreated despite its impact on survival. While transcatheter therapies for other valve diseases are established, interventional treatments for tricuspid regurgitation are emerging but require further research.

More Related Videos

A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair
08:31

A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair

Published on: October 16, 2021

4.6K
Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels
08:12

Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels

Published on: May 26, 2023

2.8K

Related Experiment Videos

Last Updated: Apr 3, 2026

Cox-Maze IV Procedure Concomitant with Valvular Surgery In Situs Inversus Dextrocardia: A Single-Center Experience in China
08:42

Cox-Maze IV Procedure Concomitant with Valvular Surgery In Situs Inversus Dextrocardia: A Single-Center Experience in China

Published on: February 11, 2022

4.5K
A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair
08:31

A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair

Published on: October 16, 2021

4.6K
Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels
08:12

Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels

Published on: May 26, 2023

2.8K

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Structural Heart Disease

Background:

  • Tricuspid regurgitation (TR) significantly impacts patient functional status and long-term survival.
  • Despite its clinical importance, TR remains undertreated compared to other valvular heart diseases.
  • Established transcatheter therapies exist for aortic, mitral, and pulmonic valve diseases, but not yet for TR.

Purpose of the Study:

  • To review the current landscape of interventional treatments for tricuspid regurgitation.
  • To discuss the challenges and future directions in developing effective transcatheter therapies for TR.
  • To highlight the growing need and interest in treating TR via interventional approaches.

Main Methods:

  • Review of current literature on transcatheter tricuspid valve interventions.
  • Analysis of emerging devices and early-stage clinical data.
  • Discussion of the evolving role of catheter-based treatments in structural heart disease.

Main Results:

  • Various promising devices for TR are in development, but clinical and functional success is not yet established.
  • Optimal patient selection for interventional TR treatment remains unclear.
  • The field is rapidly evolving, mirroring advancements in other structural heart interventions.

Conclusions:

  • Interventional treatment for tricuspid regurgitation is in its nascent stages.
  • Further research and device development are crucial to determine the future of transcatheter TR therapy.
  • The growing interest signifies a shift towards addressing this previously undertreated condition.